Assessment of the role of Anti‐thymocyte globulin in matched sibling donor hematopoietic stem cell transplantation (MSD‐HSCT) after reduced intensity conditioning in Myelodysplastic syndrome
Latest Information Update: 02 Feb 2021
Price :
$35 *
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Graft-versus-host disease; Myelodysplastic syndromes; Transplant rejection
- Focus Therapeutic Use
- 02 Feb 2021 New trial record